| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |